EGFR and non-small cell lung carcinoma: In another study involving 57 EGFR mutation‐positive NSCLC patients who had undergone repeat biopsy after failure of treatment with a first‐ or second‐generation EGFR‐TKI, acquired T790M mutation was identified in 27 patients (47%).18